Background: Neuropsychiatric signs are critical in primary caregiving of Alzheimer patients and have not yet been fully inves tigated in murine models. Methods: 18monthold 3×TgAD male mice and their wildtype male littermates (nonTg) were used. The open field test and the elevated plus maze test were used to evaluate anxietylike behaviors, whereas the Porsolt forced swim test, the tail suspension test, and the sucrose preference test for antidepressant/depressioncoping behaviors. Neurochemical study was conducted by microdialysis in freelymoving mice, analyzing the basal and K
Introduction
Alzheimer's disease (AD) is characterized by progressive impair ment of memory accompanied by neuropsychiatric disturbances (Assal and Cummings, 2002) . Several studies have shown that depression is a risk factor for AD and that patients with mild cog nitive impairment and depression have more than twice the risk of developing Alzheimertype dementia than patients without depression (Steffens et al., 1997; Modrego and Ferrández, 2004) . Although many pharmacological tools are currently available, different clinical studies suggest that the use of antidepressants as a class of medications for the treatment of depression in AD patients appears quite weak (Pomara and Sidtis, 2007; Sepehry et al., 2012) . In this regard, many factors might account for the lack of a clear benefit of antidepressants in the comorbid depres sion (e.g. methods of assessment, diagnostic criteria, stages of the dementia; Sepehry et al., 2012) . From the neurobiological perspec tive, we cannot exclude that amyloidβ (Aβ) and tau pathologies might alter the monoamine release into the synaptic cleave, inter fering with the molecular mechanism of the antidepressants.
Hence, on the basis of the above considerations, it is possible to conclude that depression in AD is still not a wellunderstood phenomenon. Therefore, it might be urgent to further explore the monoaminergic alterations underlying the comorbid depression in AD, in order to explain the lack of the responsiveness to the therapy. In this regard, analysis of postmortem brain tissue from patients with AD have revealed disturbances of the noradrener gic and serotonergic systems in the brain, whilst the results con cerning the dopaminergic system are conflicting (Nyberg et al., 1985; Gottfries, 1990; Palmer and Dekosky, 1993) . Most studies on the monoamine systems in AD have examined postmortem material, which implies that the samples have been drawn from terminal cases and results were limited to correlational studies.
To better address the involvement of monoaminergic trans missions in the pathophysiology of depression in AD, animal models provide significant advantages that extend beyond mere correlation. In this regard, the triple transgenic model of AD (3×TgAD), which harbors three mutant human genes (APP swe , PS1 M146V , and tau P301L ), has been one of the most thoroughly char acterized (Oddo et al., 2003b) . The 3×TgAD mice develop amyloid plaques and neurofibrillary pathology in a hierarchical manner in ADrelevant brain regions, and closely mimic the disease progres sion in humans (Oddo et al., 2003a (Oddo et al., , 2003b Billings et al., 2005) .
More recently, we have demonstrated that 18monthold 3×Tg AD mice presented severe deficits in odorbased memory without gross changes in general odorperceiving ability, and alterations in the glutamatergic transmission that coexists with mitochon drial dysfunction (Cassano et al., 2011 (Cassano et al., , 2012 .
Moreover, 3×TgAD mice have been evaluated in tests of exploratory activity, including the openfield test (GiménezLIort et al., 2007; Pietropaolo et al., 2008 Pietropaolo et al., , 2009 Yao et al., 2009; Arsenault et al., 2011; Ojha et al., 2011) and elevated plusmaze (EPMT; Carroll et al., 2007) . In the openfield test, there have been conflicting reports: hyperactivity in two studies (GiménezLIort et al., 2007; Pietropaolo et al., 2008) ,hypoactivity in others (Nelson et al., 2007; Pietropaolo et al., 2009; Arsenault et al., 2011) , or else no change (Ojha et al., 2011) . In the EPMT, 3×TgAD mice displayed excessive anxiety relative to nonTg mice in one study (Pietropaolo et al., 2009 ), but no change was reported in a second one (Pietropaolo et al., 2008) . Therefore, in our study we sought to reexamine this question by evaluating exploratory activity in the openfield test and the EPMT and, mostly, to evaluate more comprehensively the depressivelike phenotype of 3×TgAD mice, which has not been fully investigated.
Furthermore, we investigated whether abnormalities in mon oaminergic systems might coexist with a depressivelike and/ or anxietylike behavior in our AD model. Neurochemical study was conducted by microdialysis in freelymoving mice, analyz ing the basal and K + stimulated monoamine output in the fron tal cortex (FC) and ventral hippocampus (vHIPP), the two areas most affected by ADpathologies and highly involved in the regulation of depressive/anxietyrelated behavior. Moreover by immunohistochemistry, we analysed the expression of Tyrosin hydroxylase (TH) and Tryptophan hydroxylase (TPH), which play a key role in the synthesis of neurotransmitters.
Materials and Methods

Subjects
18monthold 3×TgAD male mice and their wildtype male lit termates (nonTg) were used. Colonies of 3×TgAD mice and nonTg littermates were maintained under standard conditions (12:12 light-dark cycle; temperature at 22°C; 50-60% relative humidity; ad libitum access to food and water). The 3×TgAD mice background strain is C57BL6/129SvJ: hybrid and genotypes were confirmed according Oddo et al. (2003b) .
All the experiments were performed in strict compliance with the Italian National Laws (DL 116/92) and the European Communities Council Directives (86/609/EEC). All efforts were made to minimize the number of animals used and their suffering.
Behavioral Assay
The open field test (OFT) and the EPMT were used to evaluate anxietylike behaviors, whereas the Porsolt forced swim test (FST), the tail suspension test (TST), and the sucrose preference test (SPT) for antidepressant/depressioncoping behaviors. A 3 to 4day interim period was interlaced between tests. All tests were performed in a dimly lit environment and under minimal anxiogenic conditions. Behavior was videotaped with a camera and scored by an observer unaware of genotypes and treatments.
Anxiety-Related Tests
The OFT was performed as previously described (Cassano et al., 2011) . Briefly, nonTg and 3×TgAD mice were each placed at the center of the arena (28 × 28 cm white Plexiglas box with walls 15 cm high) and left to explore the whole field for 30 min of recording. The ethological measures analyzed included fre quency and duration of rearing, thigmotaxis, time spent in self grooming, and locomotor activity.
The EPMT was performed as previously described (Bambico et al., 2010) . Briefly, the Plexiglas apparatus was raised 60 cm above ground and consisted of two opposite, open arms (30 × 5 cm) and two closed arms (30 × 5 × 15 cm) that extended from a common central platform (5 × 5 cm). During a 5 min observation period the following parameters were measured: 
Depression-Related Tests
The FST was performed as previously described (Bambico et al., 2010) . Briefly, 30 min after either desipramine (20 mg/kg) or vehi cle administration, mice were placed individually into Plexiglas cylindrical bins (20 cm diameter, 50 cm high) filled with water (25-27°C water temperature) to a depth of 20 cm. Desipramine was dissolved in saline and injected intraperitoneally in a vol ume of 10 ml/kg of body weight. The immobility time was the ethologically relevant parameter, and each mouse was consid ered immobile when making only those movements necessary to keep its head above water. The mice were allowed to swim for 6 min and the total duration of activity was determined during the last 4 min.
The TST was performed as previously described (Bambico et al., 2010) . In particular, the mouse was suspended by the tail from a lever in a 30 × 30 × 30 cm whitepainted enclosure, 30 min after either desipramine (20 mg/kg) or vehicle administration (intraperitoneally). Movements were recorded and quantified for 6 min, although only the last 5 min were used for analysis. Immobility was defined as hanging passively and completely motionless.
For our SPT, mice were isolated in small cages (22.5 × 16.7 × 14 cm). They each had free access to two drinking bottles, one filled with 250 ml tap water and the other with a 2% sucrose solution. Prior to testing, there was a 48 h adaptation period to habituate to the different types of fluid. The mice were subsequently deprived from food and liquids for 3 h. During the next 24 h, free consumption of water and 2% sucrose solution took place, in the presence of ad libitum food. Fluid intake was measured afterwards by weighing the drinking bottles. Sucrose preference was calculated from the amount of sucrose solution consumed, expressed as a percentage of the total amount of liq uid drunk.
Microdialysis in Freely-Moving Mice and HPLC Analysis
The microdialysis was performed according to Cassano et al. (2012) . Briefly, anaesthetized mice were doubleimplanted with both a CMA/7 probe (6 kDa cutoff; 2 mm membrane length; CMA Microdialysis) placed vertically into the right vHIPP (anteriorposterior, 3.0 mm; lateral, +3.0 mm; ventral, 1.8 mm from bregma; Figure 2B ) and a handmade microdi alysis linear probe (AN69 Hospal S.p.A; 20 kDa cutoff; 3 mm membrane length) placed horizontally into the FC (anterior posterior, +5.9 mm; ventral, 4.0 mm from interaural line; Figure 2A ) according to the stereotaxis atlas of Franklin and Paxinos (1997) .
The day of the experiment, each probe was perfused with a KrebsRinger phosphate (KRP) buffer at a flow rate of 1 μl/min and dialysates were collected every 30 min. The constituents of the KRP buffer were (in mM) NaCl 145, KCl 2.7, MgCl 2 1, CaCl 2 2.4, and Na 2 HPO 4 2, buffered at pH 7.4.
Four samples were collected to establish stable baseline lev els of dopamine (DA), noradrenaline (NA), serotonin (5HT), and their respective metabolites: homovanillic acid, 3methoxy4hy droxyphenylethyleneglycol, and 5hydroxyindoleacetic acid.
Thereafter, in order to investigate the effects of potassium (K + ) stimulation on cortical and hippocampal aminergic neu rotransmitters, both probes were perfused for 30 min with KCl (100 mM)enriched KRP buffer and then a further 6 samples were collected with the previous KRP buffer. Finally, probe placements were verified histologically.
The levels of aminergic neurotransmitters and their metabo lites were determined by high liquid performance chromatog raphy (HPLC), as previously described by Cassano et al. (2011) .
Immunohistochemistry
Immunohistochemical staining for Aβ and tau were performed as previously described (Oddo et al., 2003b; Cassano et al., 2011 Cassano et al., , 2012 Bedse et al., 2014) .
Briefly, 50 μm thick freefloating coronal sections were incu bated with the following antibodies: mouse monoclonal 6E10 antibody (1:3000 dilution, Signet Laboratories) for total amy loid; and humanspecific antitau antibody HT7 (1:1000 dilution, Pierce Biotechnology). Sections were developed with a diamin obenzidine substrate using the avidinbiotin horseradish per oxidase system (1:200 dilution, Vector Laboratories).
For TH and TPH immunostaining, sections were treated with 0.3% H 2 O 2 in methanol for 20 min to inactivate endogenous peroxidase, were exposed to blocking serum (2% normal goat serum) for 1 h at room temperature, and were incubated over night at room temperature with an antimouse biotinylated antibody (1:600 dilution AntiTH, Millipore; 1:1000 dilution AntiTPH, Sigma). Sections were washed and then incubated in biotinylated goat antimouse serum (1:500 dilution, Jackson ImmunoResearch) for 60 min at room temperature. After an additional 10 min rinsing with 0.1M PB, sections were treated with the avidinbiotin horseradish peroxidase system and developed with diaminobenzidine.
All stained sections were dehydrated in ascending ethanol concentrations, cleared in xylene, and mounted with the Eukitt mounting medium (SigmaAldrich). Slice images were captured using a Nikon 80i Eclipse microscope (Nikon, Tokyo, Japan) and the intensity of each protein's immunostaining was measured semi quantitatively as regional optical density using the Scion Image software. The averaged optical densities of nonimmunoreactive regions of each section were used for background normalization.
Statistical Analyses
All data were expressed as mean ± SEM. Most of the behavioral data failed to meet the homoscedasticity assumption. In fact, withingroup variability was analysed through Levene test for homogeneity of variances; therefore, data were analyzed by MannWhitney nonparametric U test (data from the OFT, EPMT, and SPT) and Kruskal-Wallis ANOVA followed by orthogonal chisquare (χ 2 ) partitioning to test the main effects of geno type, treatment, and genotypebytreatment interaction, each with one degree of freedom (χ 2 1 ). A Mann-Whitney U test with Bonferroni's correction was used as the post hoc test for multi ple comparisons.
Neurochemical data were homoscedastic, as shown by the Levene test for homogeneity of variances; therefore, data were analyzed by twoway ANOVA for repeated measures, with time as the within variable and genotype as the between variable. Dunnett's and Bonferroni's post hoc comparisons were used where appropriate. Unpaired ttests were used to evaluate dif ferences between genotypes for the average basal extracellular levels of each of the neurotransmitters and their metabolites (obtained as the marginal means of the 4 baseline samples).
Immunohistochemical results were calculated as a percent age of controls. The intensity of Aβ, tau, TH, and TPH immu nostaining was measured semiquantitatively as regional optical density. For each animal, measurements were obtained in at least 3 consecutive sections containing the region of interest. For each region of interest, the results were analyzed by unpaired ttest. Because of the difference in the number of slides examined, the error degrees of freedom were kept con stant at 6 based on the number of animals per group (n = 4). The threshold for statistical significance was p < 0.05.
Results
Anxiety-Like Phenotype in 3×Tg-AD Mice
Statistical analysis of the ethological parameters measured in the OFT revealed that both rearing frequency and rearing dura tion were significantly lower in 3×TgAD than in nonTg mice (frequency: 68%, U = 1.5, n = 8 per group, p = 0.0016; duration: 60%, U = 7.0, n = 8 per group, p = 0.0099; Figure 1A and B, respec tively). As for thigmotaxis, although not significant, 3×TgAD mice spent more time in the corners and along the walls com pared to nonTg mice (+21%, U = 18.5, n = 8 per group, p = 0.1719; Figure 1C) ; likewise, statistical analysis of grooming behav ior showed a trend toward an increase in 3×TgAD mice com pared to nonTg mice (+133%, U = 27, n = 8 per group, p = 0.6454; Figure 1D ).
Statistical analysis of the ethological parameters measured in the EPMT did not reveal any overall difference between mutant and nonTg mice ( Figure 1E-H As we have already reported, mouse locomotor activity measured as number of squares crossed during the 30 min ses sion was identical in both genotypes (Cassano et al., 2011) .
Depressive-Like Phenotype in 3×Tg-AD Mice
We next tested the depressivelike phenotype of 3×TgAD mice in two models of stresscoping behavior (FST and TST) and with an anhedonia test. Figure 1I presents the behavioral profile in the FST com paring differences in immobility. KruskalWallis ANOVA for immobility time revealed the following significant differences: H = 31.64, df = 3, p < 0.001, n = 10 per group. The orthogonal partitioning of the KruskalWallis H revealed a significant main effect of genotype (Χ = 0.041, p = 0.84). Post hoc comparisons showed that the immobility duration was higher (p < 0.05) in vehicletreated 3×TgAD mice than in vehicletreated nonTg mice. Moreover, the administration of desipramine significantly reduced (p < 0.05) the immobility duration only in nonTg mice but not in 3×TgAD mice, therefore a significant difference (p < 0.05) between them was still observed after drug treatment. Figure 1J presents the behavioral profile of 3×TgAD and non Tg mice in the TST. KruskalWallis ANOVA for immobility time showed the following significant differences: H = 28.43, df = 3, p < 0.001, n = 10 per group. The orthogonal partitioning of the KruskalWallis H revealed a significant main effect of genotype (Χ Post hoc comparisons showed that the immobility duration was higher (p < 0.05) in vehicletreated 3×TgAD mice than in vehicletreated nonTg mice. The administration of desipra mine significantly decreased (p < 0.05) the immobility duration in nonTg mice but not in the 3×TgAD mice, therefore a signifi cant difference (p < 0.05) between them was still observed after drug treatment. Figure 1K presents the behavioral profile of 3×TgAD and nonTg mice in the SPT. We found a significantly increased pref erence for sucrose in the nonTg group compared to the 3×Tg AD mice (U = 6.0, n = 9 per group, p = 0.0019). The effect was not accounted for by a difference in total fluid intake (fluid intake nonTg mice: 10.22 ± 1.579, n=9 per group; fluid intake 3×TgAD mice: 10.00 ± 1.616, n=9 per group). The increased preference by nonTg mice for sucrose is consistent with an antidepressant like phenotype suggested by results in the FST and TST.
Impaired Basal Aminergic Neurotransmitter Function in 3×Tg-AD Mice
Since basal extracellular aminergic neurotransmitters in each brain region of nonTg mice and 3×TgAD mice did not dif fer significantly across experiments, the basal values for each experimental group were pooled and taken as an average of dialysate samples 1-4, measured after a 2 hour stabilization period. NA, DA, 5HT (see histograms in Figure 2C , E, and G), and their metabolite (see Table 1 ) levels were significantly reduced in the FC of 3×TgAD mice compared to the control group; like wise, the basal NA (see histogram in Figure 2D ) and 3methoxy 4hydroxyphenylethyleneglycol (see Table 1 ) levels in vHIPP of 3×TgAD mice were respectively reduced by 35% and 46% com pared with nonTg mice. DA (see histogram in Figure 2F ) and its major metabolite, homovanillic acid (see Table 1 ), were not different in the vHIPP of the two genotypes. Moreover, due to the experimental conditions of analysis, we were not able to detect the 5HT levels in the vHIPP; nevertheless, the basal level of the 5HT major metabolite, 5hydroxyindoleacetic acid was signifi cantly reduced by 62% in the vHIPP of 3×TgAD mice compared to nonTg mice (see Table 1 ).
Impaired K + -Evoked Output of Aminergic Neurotransmitters in 3×Tg-AD Mice
As shown in Figure 2C and D, twoway ANOVA revealed that K + stimulation significantly raised extracellular NA release in both genotypes, either in the FC [F (time)7,91 = 6.815, p < 0.001; F (time x geno type)7,91 = 4.716, p < 0.001; F (genotype)1,13 = 2.495, n.s.; 3×TgAD mice, n = 6; nonTg mice: n = 9] and vHIPP [F (time)7,119 = 6.231, p < 0.001; F (time x genotype)7,119 = 3.076, p < 0.05; F (genotype)1,17 = 3.785, n.s.; 3×TgAD mice, n = 11; nonTg mice, n = 8]. However, betweengenotype comparisons (Tukey's test) indicated that K + induced increases in NA levels were significantly attenuated in 3×TgAD mice in both brain regions. Cortical extracellular NA reached 331 and 111 pg/ml in nonTg (186% of basal values) and 3×TgAD mice (168% of basal values), respectively, whilst hippocampal NA lev els rose to 98 and 54 pg/ml in nonTg (182% of basal values) and 3×TgAD mice (155% of basal values), respectively.
As far as the K + evoked extracellular release of DA, we observed a surprising difference between genotype, and the disparity was confirmed in both brain regions ( Figure 2E and F). In fact, the twoway ANOVA for repeated measures (actual values, mean of baseline and seven consecutive samples after high K + retrodialysis administration) showed the following differences: in the FC, F (time)7,91 = 7.610 with p < 0.001, F (time x geno type)7,91 = 7.447 with p<0.001, and F (genotype)1,13 = 11.05 with p < 0.01 (3×TgAD mice, n = 8; nonTg mice, n = 7); and in the vHIPP, F (time)7,98 = 8.374 with p < 0.001, F (time x genotype)7,98 = 7.118 with p < 0.001, and F (genotype)1,14 = 10.04 with p < 0.01 (3×TgAD mice, n = 9; nonTg mice, n = 7). In particular, a high K + challenge signifi cantly increased extracellular DA release in both the FC and vHIPP of nonTg mice (12141% and 5421% of basal value, respec tively), but had no significant effect in the same brain regions of 3×TgAD mice (247% and 251% of basal value, respectively).
As well as dopaminergic transmission, depolarization induced 5HT release in FC was significantly decreased in the 3×TgAD mice when compared with nonTg mice ( Figure 2G ). In this regard, the twoway ANOVA for repeated measures (actual values, mean of baseline and seven consecutive samples after high K + retrodialysis administration) showed the follow ing results in the FC: F (time)7,84 = 5.392 with p < 0.001, F (time x geno type)7,84 = 2.813 with p < 0.05, and F (genotype)1,12 = 8.046 with p < 0.05 (3×TgAD mice, n = 6; nonTg mice, n = 8). In particular, in non Tg mice 5HT reached 2668 pg/ml (225% of basal values) after 30 min of high K + retrodialysis administration, whereas at the same timepoint extracellular 5HT levels peaked at 537 pg/ml (177% of basal values) in 3×TgAD mice. mice showed significantly lower rearing frequency (A) and rearing duration (B), whereas no differences were observed in the thigmotaxis (C) and grooming behavior (D) between genotypes. Genotype did not significantly influence the ethological parameters measured in the EPMT (E-H). Compared to the nonTg counterpart, 3×TgAD mice spent significantly more time immobile in the FST (I) and TST (J); desipramine decreased the immobility duration only in the nonTg mice, both in FST (I) and TST (J). The nonTg group showed a significantly higher sucrose preference compared to the 3×TgAD mice (K). Data are expressed as mean ± S.E.M.*p < 0.05, **p < 0.01, main effect of genotype; °p < 0.05, main effect of desipraminetreatment. 
3×Tg-AD mice Show Diffuse Pathologies Without Gross Alterations in Immunostaining
The 3×TgAD mice showed extracellular Aβ deposits and human taureactive neurons in the cortical and some subcorti cal regions (Figure 3 ). In particular, although Aβ deposits were observed in the FC, caudatus putamen, amygdala, and vHIPP, the ventral midbrain (substantia nigra, ventral tegmental area, and dorsal raphe) and brainstem regions (locus coeruleus) were gen erally free of Aβ deposits. Moreover, extensive human tau immu noreactivity in 3×TgAD mice was particularly evident in the FC, all the forebrain regions analyzed (caudatus putamen, nucleus accumbens, and amygdala), the vHIPP, and the locus coeruleus. None of these immunoreactive structures were detected in non Tg brains.
To determine whether Aβ and tau pathologies were associ ated with abnormalities in monoaminergic systems, sections from brains of 18monthold 3×TgAD and nonTg mice were immunostained for TH and TPH (Figure 4) . Despite the neu ropathological hallmarks of AD being spread out in different brain regions of the mutant mice, surprisingly, we observed few significant differences between genotypes in the TH and THP immunostaining. In particular, TH + neurons were significantly lower (16%) in the caudatus putamen, as well as TPH + neurons (16%) in the dorsal raphe of 3×TgAD compared to nonTg mice. Conversely, the vHIPP showed a significant increase of TPH + neu rons (+22%) in the mutant mice compared to control mice.
Discussion
The results of the present study demonstrate that depressivelike but not anxiogeniclike phenotypes coexist with deficits of monoaminergic neurotransmissions in 18monthold 3×Tg AD mice, which show substantial amounts of amyloid plaques and tau pathologies in their cortical regions and limbic areas. Moreover, we observed that desipramine did not reverse the depressivelike phenotype in 3×TgAD mice. The current study provides a comprehensive evaluation of depressionlike and anhedonia features in 3×TgAD mice. To our knowledge, only a few studies have evaluated the nonmnemonic characteristics of the 3×TgAD model (GiménezLIort et al., 2007; Pietropaolo et al., 2008; España et al., 2010; Sterniczuk et al., 2010; Filali et al., 2012) , but none of them have fully evaluated such specific noncogni tive domain.
In our study we found that 3×TgAD mice exhibited higher immobility time compared with nonTg mice in the FST and TST. In contrast, the motor function and anxietyrelated emo tional response of the 3×TgAD mice were normal, although we observed a significant reduction of the frequency and the dura tion of rearing events. None of the other parameters evaluated in the OFT and EPMT were able to differentiate between genotypes, as preoviously reported (GiménezLIort et al., 2007; Pietropaolo et al., 2008; Pietropaolo et al., 2009) . Furthermore, 3×TgAD mice showed body weights that were not significantly different from nonTg mice. Therefore, the enhanced immobility time of 3×Tg AD mice is unlikely to have been caused by a deficit in motor function, a change in their anxiety level, or an increase in body weight. Differently, an increased level of anxiety was found by other authors (Sterniczuk et al., 2010; Filali et al., 2012) , when 3×TgAD mice were tested in the EPMT. In particular, Sterniczuk and colleagues (2010) tested younger 3×TgAD female mice (6 mice with mean age 9.25 months), whereas Filali and colleagues (2012) tested 12monthold 3×TgAD female mice showing an increased anxiety, though only with the headdipping measure.
Furthermore, España and colleagues (2010) found that 6monthold 3×TgAD male mice showed a significant increase of freezing responses in the brightlylitchamber test compared to nontransgenic mice, when they were exposed to an anxio genic stimulus such as a bright light (1850 lux).
Therefore, the discrepancy may be attributed to the differ ences in the experimental contexts (dim versus bright light), and mostly due to the use of different ages and sexes, which may have affected the assessment of the anxietylike phenotype in our experiments versus those reported by other authors. In fact, it has been already shown that the female (but not male) 3×Tg AD mice showed increased anxiety (Pietropaolo et al., 2009) .
Moreover, 3×TgAD mice showed a significant decrease in sucrose preference, a putative indicator of anhedonia in rodents. Taken together, our results are consistent with the hypothesis of increased depressionlike behavior and hedonic deficit in our murine model of AD; these data are concordant with findings of increased apathy and depression in Alzheimer patient (Ballard et al., 2008) .
Hypothalamicpituitaryadrenal axis alteration, which is known to be involved in the etiopathology of depression (Belmaker and Agam, 2008; Yu et al., 2008; Wuwongse et al., 2010) , has been observed in 3×TgAD mice from 9 months of age (Green et al., 2006) ; therefore, we cannot rule out that the depressivelike behavior observed in aged 3×TgAD mice might be due to their higher plasma corticosterone levels and altered glucocorticoid receptor and corticotropinreleasing hormone compared to agematched nonTg mice (Green et al., 2006; HebdaBauer et al., 2013) .
Interestingly, we observed that the NA reuptake inhibitor, desipramine, did not reduce the immobility time in the 3×Tg AD mice. These results are in line with clinical evidences where conventional antidepressants have not been found to be effec tive in depression associated with AD (Pomara and Sidtis, 2007) . In this regard, a recent systematic review evaluated the efficacy and safety of antidepressants compared with placebos in treat ing depression in patients with dementia (Leong, 2014) . The author highlighted that the evidence for antidepressants in the treatment of depression in individuals with dementia is incon clusive (Leong, 2014) . The American Psychiatric Association (2007) and the Canadian Medical Association Journal (2008) both recommended a trial of an antidepressant to treat clinically significant, persistent depressed mood in demented patients. Serotonin reuptake inhibitors were the preferred agents based NonTg 9.0 ± 1.0 (n=9) 47.0 ± 12.1 (n=9) 68.2 ± 10.4 (n=9) 67.7 ± 11.7 (n=9) 1.9 ± 0.4 (n=10) 0.7 ± 0.2 (n=8) 1.0 ± 0.1 (n=10) 22.0 ± 2.9 (n=10) 3×TgAD 5.5 ± 0.8* (n=7) 6.9 ± 2.1** (n=9) 31.2 ± 7.9* (n=9) 30.9 ± 6.5* (n=8) 1.0 ± 0.1* (n=9) 0.04 ± 0.02* (n=8) 0.8 ± 0.1 (n=9) 8.4 ± 1.9* (n=8)
Data are expressed as mean ± S.E.M. *p < 0.05 and **p < 0.01 versus nonTg mice (unpaired student's ttest) on their tolerability profile (minimal anticholinergic activ ity) compared with other classes of antidepressants. However, a systematic review did not support the efficacy of serotonin reuptake inhibitor treatment for symptoms of comorbid depres sion in AD (Sepehry et al., 2012) . In contrast, all three major antidepressant classes (tricyclics, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors) appear effective in the treatment of depression in the nondemented elderly compared to placebo (Wilson et al., 2008) . Therefore, in accord ance with other authors, we agree that depression in dementia is likely different from depression in aging, and that its treat ment cannot be extrapolated from treatment approaches in the normal elderly. Hence, such evidences prompted us to explore whether a depressivelike phenotype correlates with alterations of monoamine neurotransmitters in the AD model. In particular, with the exception of the hippocampal dopaminergic system, we found a significant reduction in basal extracellular release of the monoamine neurotransmitters in both the FC and vHIPP of 18monthold 3×TgAD mice versus nonTg mice. Although not significant, the basal output of the DA and its metabolite, homovanillic acid, in the vHIPP was reduced (21% and 13%, respectively) in the 3×TgAD mice. Likewise, GuzmànRamos et al. (2012) showed that the basal levels of NA were lower than those of controls in both the insu lar cortex and the dorsal hippocampus of 10monthold 3×Tg AD mice; moreover, they found that the basal DA levels were significantly lower in the 3×TgAD mice compared to nonTg mice only in the insular cortex. It has been demonstrated that synaptophysin, a presynaptic vesicle marker commonly used as an estimate of synaptic density, is not altered in either the cortex or the hippocampus of either genotype (Chen et al., 2000; Oddo, Caccamo, Kitazawa, et al. 2003; Oddo et al., 2003b; Cassano et al., 2012) ; therefore, it is unlikely that the lower basal levels of amines might be due to a synaptic loss.
Moreover, the pattern of monoamine release in response to K + stimulation resulted in complete disruption in both the FC and vHIPP of 3×TgAD mice, but not in nonTg mice. In particu lar, 30 min from the beginning of K + stimulation, we observed a blunted NA release above the baseline in the FC (+60% in 3×Tg AD versus +80% in nonTg) and vHIPP (+50% in 3×TgAD versus +80% in nonTg). Conversely, we observed a complete absence of DA peak release in response to K + stimulation in both brain regions; likewise, 5HT did not respond to a K + depolarizing stimulus in the FC.
We have recently demonstrated that the complete absence of neurotransmitter peak release in response to K + stimulation is consistent with a low energy level in the brain region, which, in turn, might be insufficient to ensure all those neuronal func tions stimulated by K + , such as axonal transport, exocytosis, and the activity of the Na + /K + ATPase pump (Cassano et al., 2012) . Likewise, we cannot rule out that alterations of the molecular mechanisms governing synaptic vesicle trafficking and neuro transmitter release might account for the altered response to K + stimulation. In fact, we have demonstrated that the 25kDa synaptosomalassociated protein (SNAP25), one of the synap tic vesicle exocytosis proteins in the soluble Nethylmaleimide sensitive factor attachment protein receptors, was significantly reduced in the hippocampus of 3×TgAD mice compared with nonTg mice, whereas no difference was observed in the FC (Cassano et al., 2012) .
Extracellular aminergic levels are tightly coupled to the activity of brain TH and TPH, two ratelimiting enzymes in the synthesis of DA, NA, and 5HT. Given the decreases in the aminergic system in the FC and vHIPP of 3×TgAD mice, we quantified the level of both enzymes in different brain regions. Besides a significant reduction in the caudatus puta men of 3×TgAD mice, no effect of genotype on the levels of TH was observed, suggesting that the differences in amine and metabolite levels cannot be explained by a decrease of TH levels (or by a decrease in the number of THpositive neurones). Our result agrees with one clinical study, where authors have dem onstrated decreased levels of striatal TH in postmortem brain tissue taken from patients with AD when compared to control brains (Nagatsu and Iizuka, 1989) . Just as with the TH, surpris ingly, we found modest alterations of TPH expression among the brain regions, which cannot account for the total lack of responsiveness to KCl stimulation in the FC. In particular, we found a significant increase of TPH expression in the vHIPP and a significant decrease in the dorsal raphe. Despite the effects described above, no differences in other brain regions were detected. Increased hippocampal 5HT fiber density in the 18monthold 3×TgAD were observed in proximity to amy loid plaques, suggesting that aberrant 5HT neuronal sprouting and amyloid deposition are closely linked in AD neuropathol ogy (Noristani et al., 2010) . The massive buildup of plaques at a later age (18 months) may induce neurotoxic effects, result ing in neuronal damage that, in turn, may also stimulate an increase in 5HT fibers in the hippocampus of 3×TgAD mice. Increased 5HT fiber sprouting was also found after acute brain damage, such as Aβ, ibotenic acid, and NMDA injection in rats (Zhou et al., 1995; Harkany et al., 2000) . Thus, serotonergic fiber sprouting may act as a compensatory mechanism to counteract Aβ and tauinduced neurotoxicity. In fact, it has been reported that 5HT fiber sprouting was further increased in the hip pocampi of 24monthold 3×TgAD mice, which showed mas sive extracellular Aβ plaques and large tau pathology (Noristani et al., 2011) . Speculatively, it is conceivable that amyloid plaques and tau pathologies might profoundly disrupt the functioning of neurons that contain aminergic neurotransmitters in the presynaptic terminals, potentially leading to a depressivelike phenotype and, more interestingly, to a lack of response of anti depressant treatment.
